Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Kevzara
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Immunology
Currency : USD
2019 Revenue in Millions : 202
2018 Revenue in Millions : 90
Growth (%) : 123
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Immunology
Currency : USD
2020 Revenue in Millions : 285
2019 Revenue in Millions : 224
Growth (%) : 28
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Immunology
Currency : USD
2021 Revenue in Millions : 316
2020 Revenue in Millions : 257
Growth (%) : 22
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 372
2021 Revenue in Millions : 316
Growth (%) : 18
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Immunology
Currency : USD
2023 Revenue in Millions : 385
2022 Revenue in Millions : 372
Growth (%) : 5
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Rheumatoid Arthritis
Currency : USD
2017 Revenue in Millions : 14
2016 Revenue in Millions : 0
Growth (%) : New Launch
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Autoimmune Disorders
Currency : USD
2018 Revenue in Millions : 94
2017 Revenue in Millions : 12
Growth (%) : 655%
LOOKING FOR A SUPPLIER?
